Presidents: Dino Amadori, Rosella Silvestrini
Topics
The Conference aims to examine the link between research into cancer and clinical applications of laboratory findings, and to focus on the biomolecular development of new biological drugs. The conference also aims to promote open dialogue between laboratory researchers, clinical oncologists and pharmaceutical companies, of fundamental importance for the successful translation of research into practice.
Areas of interest are as follows:
Topics
The Conference aims to examine the link between research into cancer and clinical applications of laboratory findings, and to focus on the biomolecular development of new biological drugs. The conference also aims to promote open dialogue between laboratory researchers, clinical oncologists and pharmaceutical companies, of fundamental importance for the successful translation of research into practice.
Areas of interest are as follows:
- The role of biomolecular markers in early diagnosis of cancer
- Biomolecular aspects of cancer immunotherapy
- Targets and mechanism of action:
- of therapeutic monoclonal antibodies
- of small molecule drugs
- of chemotherapeutic agents
- Mechanisms of endocrine resistance and therapeutic strategies to overcome it
- Molecular characterization and therapy in palliative care for cancer patients
- Biomolecular aspects of supportive therapy for cancer patients
